| Primary |
| Influenza |
53.4% |
| Drug Use For Unknown Indication |
22.3% |
| Cough |
4.0% |
| Bronchitis |
3.8% |
| Antiviral Prophylaxis |
2.8% |
| Asthma |
1.9% |
| Antipyresis |
1.9% |
| Nasopharyngitis |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Productive Cough |
1.0% |
| H1n1 Influenza |
1.0% |
| Upper Respiratory Tract Inflammation |
0.8% |
| Pharyngitis |
0.8% |
| Gastroenteritis Bacterial |
0.7% |
| Antitussive Therapy |
0.7% |
| Vomiting |
0.5% |
| Dehydration |
0.5% |
| Pyrexia |
0.5% |
| Prophylaxis |
0.4% |
| Headache |
0.4% |
|
| Overdose |
22.0% |
| Drug Exposure During Pregnancy |
20.0% |
| Abnormal Behaviour |
8.0% |
| Drug Exposure Via Breast Milk |
7.7% |
| Hallucination |
7.5% |
| Loss Of Consciousness |
4.6% |
| Vomiting |
3.8% |
| Delirium |
3.3% |
| Pyrexia |
2.9% |
| Restlessness |
2.8% |
| No Adverse Event |
2.7% |
| Speech Disorder |
2.5% |
| Tremor |
1.9% |
| Vision Blurred |
1.5% |
| Hallucination, Auditory |
1.5% |
| Depressed Level Of Consciousness |
1.4% |
| Somnolence |
1.4% |
| Syncope |
1.4% |
| Urticaria |
1.4% |
| Nightmare |
1.3% |
|
| Secondary |
| Influenza |
41.1% |
| Drug Use For Unknown Indication |
13.5% |
| H1n1 Influenza |
7.1% |
| Nasopharyngitis |
5.7% |
| Hepatic Cirrhosis |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Asthma |
2.8% |
| Cough |
2.8% |
| Infection Prophylaxis |
2.8% |
| Epilepsy |
2.1% |
| Gastroenteritis |
2.1% |
| Nausea |
2.1% |
| Antiviral Prophylaxis |
1.4% |
| Bacterial Infection |
1.4% |
| Constipation |
1.4% |
| Pancreatitis Acute |
1.4% |
| Varices Oesophageal |
1.4% |
| Antipyresis |
0.7% |
| Bronchitis |
0.7% |
| Ill-defined Disorder |
0.7% |
|
| Overdose |
33.3% |
| Electroencephalogram Abnormal |
6.3% |
| Pyrexia |
6.3% |
| Restlessness |
6.3% |
| Rhinovirus Infection |
6.3% |
| Influenza |
4.8% |
| No Adverse Event |
4.8% |
| Aggression |
3.2% |
| Anaphylactic Shock |
3.2% |
| Bradycardia |
3.2% |
| Delirium |
3.2% |
| Drug Ineffective |
3.2% |
| Nervous System Disorder |
3.2% |
| Normal Newborn |
3.2% |
| Amnesia |
1.6% |
| Asthma |
1.6% |
| Death |
1.6% |
| Decreased Appetite |
1.6% |
| Gaze Palsy |
1.6% |
| Hallucination |
1.6% |
|
| Concomitant |
| Influenza |
20.6% |
| Prophylaxis |
7.5% |
| Cystitis |
5.6% |
| Immunosuppression |
5.6% |
| Metastatic Renal Cell Carcinoma |
5.6% |
| Pyrexia |
5.6% |
| Renal Transplant |
5.6% |
| Bronchitis |
4.7% |
| Biopsy Kidney |
3.7% |
| Castleman's Disease |
3.7% |
| Drug Use For Unknown Indication |
3.7% |
| Infection Prophylaxis |
3.7% |
| Insomnia |
3.7% |
| Neurogenic Bladder |
3.7% |
| Oral Herpes |
3.7% |
| Upper Respiratory Tract Infection |
3.7% |
| Allogenic Bone Marrow Transplantation Therapy |
2.8% |
| Epilepsy |
2.8% |
| Analgesic Therapy |
1.9% |
| Anxiety |
1.9% |
|
| Pneumonia |
17.1% |
| Abnormal Behaviour |
7.3% |
| Haematochezia |
7.3% |
| Pruritus |
7.3% |
| Pyrexia |
7.3% |
| Drug Resistance |
4.9% |
| Encephalopathy |
4.9% |
| Influenza |
4.9% |
| Pain |
4.9% |
| Pathogen Resistance |
4.9% |
| Pulmonary Infarction |
4.9% |
| Respiratory Disorder |
4.9% |
| Anaphylactic Reaction |
2.4% |
| Anxiety |
2.4% |
| Asthma |
2.4% |
| Bacterial Infection |
2.4% |
| Colonic Polyp |
2.4% |
| Confusional State |
2.4% |
| Depressed Level Of Consciousness |
2.4% |
| Drug Exposure During Pregnancy |
2.4% |
|
